Article Text

PDF

Management of irritable bowel syndrome
  1. M C Gunn,
  2. A A Cavin,
  3. J C Mansfield
  1. Royal Victoria Infirmary, Newcastle upon Tyne
  1. Correspondence to:
 Dr John Mansfield, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP; UK; 
 John.mansfield{at}nuth.northy.nhs.uk

Abstract

The diagnosis of irritable bowel syndrome (IBS) is made on clinical grounds with appropriate limited investigations to exclude organic disease. IBS is common and may have a significant impact on a patient’s quality of life. Psychological symptoms are common. IBS may benefit from pharmacological and non-pharmacological management. Specific measures should be directed towards the dominant symptoms of constipation or diarrhoea. Several new drugs are currently under evaluation and may prove valuable for subgroups of patients with IBS. Successful management requires a combination of reassurance and explanation about the natural history of the condition.

  • irritable bowel syndrome
  • functional bowel disease
  • psychosocial
  • fibre
  • 5-HT3, serotonin-3
  • 5-HT4, serotonin-4
  • IBS, irritable bowel syndrome
  • SSRI, specific serotonin reuptake inhibitors
View Full Text

Statistics from Altmetric.com

Footnotes

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.